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E nhanced recovery after surgery (ERAS) protocols are composed of multimodal perioperative care,  
and they have proven valuable in reducing complica-
tions,  shortening the postoperative length of hospital 
stays,  and costs [1 , 2].  Epidural analgesia (EDA) is 
considered an indispensable procedure after open 
abdominal surgery in ERAS protocols since EDA has 
been shown to provide superior pain relief and 
decreased the rate of postoperative complications after 
abdominal surgery [3 , 4].
In recent years,  laparoscopic gastrectomy for gastric 
cancer has become a standard procedure.  It has been 
reported that the laparoscopic approach is associated 
with a reduction in postoperative pain and opioid con-
sumption,  lower morbidity,  faster recovery and shorter 
postoperative length of hospital stays compared to open 
surgery [5-8].  Although EDA is an excellent pain relief 
modality,  the role of EDA in laparoscopic surgery is 
unclear.  Several clinical studies showed that the use of 
EDA slowed down the recovery after laparoscopic col-
orectal surgery [9-11].  Moreover,  the use of EDA 
requires an invasive and specialized technique for cath-
eter placement and has the potential to cause severe 
complications such as epidural hematoma or abscess 
[12].  It was also reported that one-third of EDA might 
not function adequately because of catheter misplace-
ment or deviation or an inadequate dose [13].
In postoperative pain control,  multimodal analgesia 
has been recommended because it provides excellent 
pain relief with minimized adverse events related to 
analgesia [14].  Patient-controlled intravenous analgesia 
(PCIA) plays an important role in multimodal analgesia 
concepts,  and is a safe,  less-invasive and effective anal-
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Although epidural analgesia (EDA) is considered standard postoperative analgesia for open gastrectomy,  it has 
been unclear whether EDA has benefits in laparoscopic gastrectomy (LG) because postoperative pain after a 
laparoscopic procedure is significantly reduced.  We are conducting a two-arm,  single-center,  prospective ran-
domized non-inferiority trial to evaluate the postoperative pain relief of patient-controlled intravenous analge-
sia (PCIA) compared to EDA.  A total of 132 patients undergoing LG will be randomized to EDA and PCIA 
groups (n = 64 each) for postoperative pain control.  The primary endpoint is postoperative pain at 24 h after 
surgery.  This study will clarify the optimal pain management after LG.
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gesia using a peripheral vein.
We are conducting a prospective,  randomized con-
trolled trial to evaluate the pain relief efficacy of PCIA 
compared to that of EDA after laparoscopic gastrec-
tomy (LG).
Methods
Study design. This is a two-arm,  single-center,  
prospective randomized non-inferiority trial to evaluate 
the postoperative pain relief provided by PCIA com-
pared to that of EDA following laparoscopic gastrec-
tomy.  This trial is being conducted at the Okayama 
University Hospital.  A total of 132 eligible patients 
undergoing laparoscopic gastrectomy have been ran-
domized to the EDA and PCIA groups (n = 64 each) for 
postoperative pain control (Fig. 1).
Ethical Consideration
This study is being conducted in compliance with the 
principles of the Declaration of Helsinki,  and this pro-
tocol has been approved by the Institutional Review 
Board of the Okayama University Hospital (No. 1705-
004).  This trial is registered with the University 
Hospital Medical Information Network Clinical Trial 
Registry (UMIN000027643).
Endpoints
The primary endpoint is postoperative pain at rest 
24 h after surgery,  which is assessed using a numerical 
rating scale (NRS) [15].  The patients’ NRS pain scores 
are graded from 0 (no pain) to 10 (imaginable worst 
pain),  and self-reported by the patients and recorded by 
the nursing staff.  Secondary endpoints include the 
achievement day of discharge criteria,  the length of the 
postoperative hospital stay,  postoperative complica-
tions,  postoperative pain on days 2 , 3 , 4 after surgery,  
additional doses of analgesics,  adverse events related to 
analgesia,  and the patient’s satisfaction.  The achieve-
ment day of discharge criteria is used to assess the 
recovery after surgery; this is considered a more spe-
cific outcome parameter than the length of postopera-
tive hospital stays because social and logistic factors are 
not interfering.  The criteria are defined as eating a 
normal diet,  no complaints of pain,  full mobilization 
comparable to that of the patient’s preoperative status,  
and no complications for 24 h.  All patients will be fol-
lowed-up until a regular checkup at approx.  1 month 
after surgery.
Postoperative complications are graded using the 
Clavien-Dindo classification system [16].  The postop-
erative pain is assessed using a NRS at rest and move-
ment,  and routine evaluation twice daily starts the 
evening of the surgery day and is continued until post-
operative day (POD) 4.  The adverse events related to 
analgesia include sedation,  postoperative nausea and 
vomiting,  hypotension,  and urinary retention.  The 
patient’s satisfaction is assessed using a 5-point Likert 
scale from very dissatisfied (1) to very satisfied (5).  
Safety related to the interventions is also being evalu-
ated.
Eligibility Criteria
All of the patients who meet the eligibility criteria 
based on the inclusion and exclusion criteria,  which are 
listed in Table 1,  are being enrolled in this study from 
July 2017 to June 2019.
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Fig. 1　 Trial ﬂowchart.  EDA,  epidural analgesia; PCIA,  patient- 
controlled intravenous analgesia.
Randomization
After the patients’ fulfillment of the eligibility criteria 
was confirmed,  the patients receive verbal and written 
information about the study,  and their written consent 
is obtained.  After registration in the Data Center,  each 
patient is randomly assigned to the EDA or PCIA group 
with the use of a computer-generated list.  Allocation is 
performed by a stratified permuted block method.  For 
medical and logistic reasons,  blinding is not performed 
because it is not realistic for this study.  The stratified 
factors are age,  sex,  American Society of Anesthesiolo-
gists (ASA) Physical Status classification,  and surgical 
procedure.
Treatment Methods
Intervention. In all patients,  the clinical path 
after LG in our institution will be used in order to stan-
dardize the perioperative treatment in two groups.  In 
the EDA group,  an epidural catheter is inserted at the 
thoracic level (Th8-10) before the induction of anesthe-
sia using loss of resistance.  The epidural space is con-
firmed by performing an absorption test and a 3-ml 
bolus of 1% lidocaine with epinephrine (dilution 
1 : 100,000).  A 5-ml bolus of 0.2% ropivacaine is started 
as soon as the epidural catheter is inserted,  and a con-
tinuous infusion or bolus injection of 0.2% ropivacaine 
with fentanyl (1 µg/ml) is performed until the end of 
surgery depending on the anesthesiologist’s decision 
based on the patient’s vital signs.
In both the EDA and PCIA groups,  the induction of 
general anesthesia is performed with propofol (target 
controlled infusion [TCI] 2-4 µg/ml),  remifentanil 
(0.2-0.5 µg/kg/min),  and rocuronium bromide (0.5-
0.6 mg/kg) for muscle paralysis.  Anesthesia is main-
tained with the total intravenous venous anesthesia 
(TIVA) technique using a propofol TCI and remifent-
anil infusion.  Rocuronium bromide is used for muscle 
relaxation as needed.  All cases will be extubated in the 
operating room if possible.
Postoperatively,  EDA is maintained at a rate of 2 to 
6 ml/h (target: NRS < 4) using an epidural patient-con-
trolled analgesia (PCA) pump.  A bolus of 3 ml is 
allowed every 15 min.  In the PCIA group,  intravenous 
fentanyl (10 µg/ml) is administered at 0-1 ml/h at the 
end of the surgery.  A bolus of 1 ml is allowed every 15  
min up to the maximal dose of 40 µg/h (target: NRS<4).
Both interventions are planned to be discontinued 
on POD 2,  but both can be continued until POD 7 if the 
analgesia team judges that a prolonged application is 
beneficial for the patient.  All patients received celecoxib 
(200 mg × 2/day,  oral) from POD 3 as baseline analge-
sia unless contraindicated.  The pain score is assessed 
twice daily at rest and on mobilization or coughing by 
nursing staff.  Additional analgesics including loxopro-
fen sodium hydrate (60 mg,  oral),  pentazocine (15 mg,  
intravenous),  flurbiprofen axetil (50 mg,  intravenous),  
and acetaminophen (1,000 mg,  intravenous) are admin-
istered when the patient complains of pain (NRS > 3).
Adverse events. The adverse events related to 
PCIA and to EDA including sedation,  postoperative 
nausea and vomiting,  hypotension,  and urinary reten-
tion are monitored during the patient’s hospital stay.  
Moreover,  severe complications such as epidural hema-
toma or abscess related to EDA are also monitored.
Statistical Consideration
Sample size. Based on retrospective data from 
our institution regarding laparoscopic gastrectomy for 
gastric cancer,  the NRS scores (mean ± standard devia-
tion) at rest 24 h after surgery were 2.11 ± 1.9 and 
2.36 ± 1.8 in the EDA group and the PCIA group,  
respectively.  In this study,  a similar population is 
included (according to the eligibility criteria) compared 
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Table 1　 Patient inclusion and exclusion criteria
Inclusion criteria
　(1)  Patients who are scheduled to undergo LG including TG,  DG,  
and PG
　(2) Aged 20-80 years
　(3) Patients who can provide written informed consent
Exclusion criteria
　(1) ASA-PS≥4
　(2) Patients undergoing anticoagulant therapy
　(3) Medical contraindication for EDA





　(9)  Otherwise judged by the investigator as unsuitable for enroll-
ment
ASA-PS,  American Society of Anesthesiologists-Physical Status;  
DG,  distal gastrectomy; EDA,  epidural analgesia; LG,  laparoscopic 
gastrectomy; PG,  proximal gastrectomy; TG,  total gastrectomy.
to the retrospective data.  Therefore,  the standard devi-
ation of NRS scores in this study is estimated to be 
smaller than that of the retrospective data.  We antici-
pate a 10% lower standard deviation compared to the 
retrospective data,  and ensuring that at least 80% 
power with a one-sided alpha of 5% and a non-inferior-
ity margin of 1 in terms of NRS score,  62 patients per 
each group are needed.  To compensate for potential 
exclusions or withdrawals,  we will include a total of 132 
patients.
Statistical analysis. Student’s T-test is used to 
analyze continuous variables.  P-values < 0.05 are con-
sidered significant.  The statistical analyses will be per-
formed by using JMP 11.2 (SAS Institute,  Cary,  NC,  
USA).
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